Peptide Hydrogels: Self-Assembling Gels That Can Deliver Drugs Slowly Over Time | Research

The takeaway

Peptide-based hydrogels are emerging as versatile injectable drug delivery systems that can protect medications, mimic body tissue, and release drugs in a controlled way.

Self-assembling drug depots
Peptide hydrogels form spontaneously from short amino acid chains and can act as injectable reservoirs that slowly release drugs — reducing the need for frequent dosing.

What the researchers found

Peptide-based hydrogels offer several advantages as controlled drug delivery systems: they self-assemble from simple peptide building blocks, are biocompatible, closely mimic the body's extracellular matrix, and can be fine-tuned in their physical properties.

Beta-sheet forming peptide sequences are highlighted as particularly versatile building blocks for hydrogel formation. The review identifies an emerging trend toward affinity-based drug release systems, which use molecular recognition rather than simple diffusion to control when and how much drug is released — offering more precise therapeutic dosing compared to conventional hydrogel approaches.

Why it matters

As biologic drugs (peptides, proteins, antibodies) increasingly dominate the pharmaceutical pipeline, the need for better delivery systems grows. Many biologics are fragile and short-lived in the body. Peptide hydrogels could serve as injectable depots that protect these drugs and release them slowly, potentially reducing injection frequency and improving patient compliance. This is especially important for the growing class of peptide therapeutics.

How the study worked

This was a comprehensive narrative review of the published literature on peptide hydrogels for drug delivery. The authors examined different types of hydrogel systems, their self-assembly processes, the variety of peptide sequences used as building blocks, and the mechanisms by which drugs are released from these systems.

What this study cannot tell us

This is a review article that summarizes the state of the field rather than reporting new experimental data. Most peptide hydrogel drug delivery systems discussed are in preclinical stages, and the review does not provide a systematic assessment of which systems have advanced to human trials. The translation from laboratory demonstrations to clinical use faces significant regulatory and manufacturing challenges that are not deeply explored.

How to read the evidence

This is a narrative review summarizing the current landscape of peptide hydrogel drug delivery technology. It provides a comprehensive overview but does not apply systematic methodology or present original experimental data, placing it at the review level of evidence.

When this study was published

Published in 2025, this is a current review that captures the latest developments in peptide hydrogel technology including the emerging trend toward affinity-based drug release systems.

The bigger picture

Drug delivery is one of the biggest bottlenecks in getting peptide therapeutics to patients. Many promising peptides fail not because they don't work, but because they break down too fast or can't reach their target. Peptide hydrogels represent an elegant solution — using peptides themselves as the delivery vehicle for other peptide drugs. As the peptide therapeutics market grows, these self-assembling delivery platforms could become critical enabling technology.

Questions still open

Which peptide hydrogel systems are closest to clinical use, and what are the main barriers to regulatory approval?
Can affinity-based peptide hydrogels achieve truly zero-order drug release (constant dosing) over weeks or months?
How do peptide hydrogels compare to other sustained-release technologies like PEGylation and lipid nanoparticles in terms of cost and scalability?

Common questions

What is a peptide hydrogel and how does it deliver drugs?

A peptide hydrogel is an injectable, water-rich gel made from short amino acid chains that self-assemble into a solid-like network. When loaded with a drug, the gel acts like a depot under the skin — slowly releasing the medication over days or weeks as the gel gradually breaks down or the drug diffuses out. This means fewer injections and more consistent drug levels in the body.

Why use peptides to make the gel instead of other materials?

Peptides are biocompatible (the body recognizes and can safely break them down), they self-assemble without harsh chemicals, and their properties can be precisely tuned by changing the amino acid sequence. They also mimic the body's own extracellular matrix, making them well-tolerated. Unlike synthetic polymers, peptide hydrogels naturally degrade into harmless amino acids.

Read the original research

The versatility of peptide hydrogels: From self-assembly to drug delivery applications.

Journal of peptide science : an official publication of the European Peptide Society, 31(2), e3662

View on PubMed ↗Publisher’s paper ↗

Citation

Heremans, Julie; Ballet, Steven; Martin, Charlotte. (2025). The versatility of peptide hydrogels: From self-assembly to drug delivery applications.. Journal of peptide science : an official publication of the European Peptide Society, 31(2), e3662. https://doi.org/10.1002/psc.3662